Drug intelligence / Profile preview

Byetalog

Development stage
Unknown
Lead developer
Wuxi Hebang Biotechnology
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Peptides
Administration
Subcutaneous
01

Overview

Byetalog (HB1085) is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist developed by Wuxi Hebang Biotechnology for the treatment of type 2 diabetes mellitus. The drug is a recombinant fusion protein consisting of exendin-4, a GLP-1 analog, fused to human serum albumin (HSA). This fusion technology is designed to significantly extend the circulating half-life of the peptide, allowing for a reduced dosing frequency compared to native GLP-1 or short-acting analogs. By activating the GLP-1 receptor, Byetalog stimulates glucose-dependent insulin secretion, inhibits glucagon release, and slows gastric emptying, thereby improving glycemic control in patients with diabetes.

Brand names
Byetalog
Other names
Exendin-4-HSA Fusion ProteinExendin4-HSA Fusion ProteinExendin 4-HSA Fusion Protein
02

Targets

Beyond the preview

Go deeper on Byetalog.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Byetalog.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call